APRE
Aprea Therapeutics Inc
Price:  
0.78 
USD
Volume:  
61,530.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

APRE Stock Forecast & Price Target

APRE Stock Price Forecast

The average stock forecast for Aprea Therapeutics Inc (APRE) in the next 12 months is 4.39 USD. This price target corresponds to an upside of 527.83%. The range of stock forecasts for APRE is 1.21 - 6.30 USD. Based on the ratings of 10 analysts, the consensus recommendation for APRE is BUY.
Target Low Average Median High
Price (USD) 1.21 4.39 5.10 6.30
Upside 73.49% 527.83% 630.03% 801.80%

Recommendation Trends

The latest consensus rating for APRE is "BUY". This is the average recommendation of 10 analysts: 0 strong sell, 0 sell, 1 hold, 5 buy, 4 strong buy. In the previous period, 9 analysts also majorly recommmended "BUY" for APRE.

APRE Financial Stock Forecast

Revenue This Year
0.73M
154.62%
from 0.29M
Revenue Next Year
1.54M
111.52%
from 0.73M
EPS This Year
-0.79
-22.34%
from -1.02
EPS Next Year
-0.72
-8.95%
from -0.79